Patient-Reported Comorbidity and Survival in Older Adults with Cancer

被引:62
作者
Williams, Grant R. [1 ]
Deal, Allison M. [2 ]
Lund, Jennifer L. [2 ]
Chang, YunKyung [2 ]
Muss, Hyman B. [2 ]
Pergolotti, Mackenzi [3 ]
Guerard, Emily J. [4 ]
Shachar, Shlomit Strulov [2 ,5 ]
Wang, Yue [2 ]
Kenzik, Kelly [1 ]
Sanoff, Hanna K. [2 ]
机构
[1] Univ Alabama Birmingham, Inst Canc Outcomes & Survivorship, Birmingham, AL 35233 USA
[2] UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA
[3] Colorado State Univ, Dept Occupat Therapy, Ft Collins, CO 80523 USA
[4] Univ Wisconsin, Div Hematol & Oncol, Madison, WI USA
[5] Rambam Hlth Care Campus, Div Oncol, Haifa, Israel
基金
美国国家卫生研究院;
关键词
Comorbidity; Multimorbidity; Cancer; Aging; Geriatric oncology; CHEMOTHERAPY TOXICITY; GERIATRIC ASSESSMENT; FEASIBILITY; ONCOLOGY; SCALE;
D O I
10.1634/theoncologist.2017-0404
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Our ability to optimize the care of older adults with cancer and comorbid illnesses is insufficient because most clinical trials lack systematic measurement. The primary purpose of this study was to evaluate the association between patient-reported comorbidity and all-cause mortality using various comorbidity scoring algorithms. Materials and Methods. The Carolina Senior Registry was linked with the North Carolina Central Cancer Registry to obtain mortality data. Comorbidity was assessed using the patient-reported Older Americans Resources and Services Questionnaire subscale that assesses 13 specific conditions and the degree to which each impairs activities. Multivariable Cox proportional hazard regression models were used to evaluate the association between comorbidities and all-cause mortality. Results. The study sample included 539 patients; the median age was 72 years, 72% were female, and 47% had breast cancer. Overall, 92% reported >= 1 comorbid condition, with a mean of 2.7 conditions (range 0-10), with arthritis and hypertension the most common (52% and 50%, respectively). Approximately 60% reported a functional limitation related to comorbidity. After adjusting for time from diagnosis to geriatric assessment, age, cancer type, and stage, the risk of death increased by 5% for each unit increase in comorbidity burden score (adjusted hazard ratio [HR] = 1.05, 95% confidence interval [CI]: 1.01-1.10) and 12% for each comorbid condition impacting function (HR = 1.12, 95% CI: 1.02-1.23). Conclusion. Comorbid conditions in older adults with cancer are highly prevalent and associated with all-cause mortality, particularly those conditions that impair function. Routine comorbidity assessment should be included in clinical trials and can be measured via a simple one-page patient-reported questionnaire.
引用
收藏
页码:433 / 439
页数:7
相关论文
共 24 条
[1]  
[Anonymous], COCHRANE DATABASE SY
[2]   Patient-Reported Outcome Performance Measures in Oncology [J].
Basch, Ethan ;
Snyder, Claire ;
McNiff, Kristen ;
Brown, Rebecca ;
Maddux, Suzanne ;
Smith, Mary Lou ;
Atkinson, Thomas M. ;
Howell, Doris ;
Chiang, Anne ;
Wood, William ;
Levitan, Nathan ;
Wu, Albert W. ;
Krzyzanowska, Monika .
JOURNAL OF ONCOLOGY PRACTICE, 2014, 10 (03) :209-211
[3]   Measuring comorbidity in older cancer patients [J].
Extermann, M .
EUROPEAN JOURNAL OF CANCER, 2000, 36 (04) :453-471
[4]   Measurement and impact of comorbidity in older cancer patients [J].
Extermann, M .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2000, 35 (03) :181-200
[5]   Predicting the risk of chemotherapy toxicity in older patients: The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score [J].
Extermann, Martine ;
Boler, Ivette ;
Reich, Richard R. ;
Lyman, Gary H. ;
Brown, Richard H. ;
DeFelice, Joseph ;
Levine, Richard M. ;
Lubiner, Eric T. ;
Reyes, Pablo ;
Schreiber, Frederic J., III ;
Balducci, Lodovico .
CANCER, 2012, 118 (13) :3377-3386
[6]   THE DEVELOPMENT, VALIDITY, AND RELIABILITY OF THE OARS MULTIDIMENSIONAL FUNCTIONAL ASSESSMENT QUESTIONNAIRE [J].
FILLENBAUM, GG ;
SMYER, MA .
JOURNALS OF GERONTOLOGY, 1981, 36 (04) :428-434
[7]   Function in elderly cancer survivors depends on comorbidities [J].
Garman, KS ;
Pieper, CF ;
Seo, P ;
Cohen, HJ .
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2003, 58 (12) :1119-1124
[8]   Developing a cancer-specific geriatric assessment - A feasibility study [J].
Hurria, A ;
Gupta, S ;
Zauderer, M ;
Zuckerman, EL ;
Cohen, HJ ;
Muss, H ;
Rodin, M ;
Panageas, KS ;
Holland, JC ;
Saltz, L ;
Kris, MG ;
Noy, A ;
Gomez, J ;
Jakubowski, A ;
Hudis, C ;
Kornblith, AB .
CANCER, 2005, 104 (09) :1998-2005
[9]   Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study [J].
Hurria, Arti ;
Togawa, Kayo ;
Mohile, Supriya G. ;
Owusu, Cynthia ;
Klepin, Heidi D. ;
Gross, Cary P. ;
Lichtman, Stuart M. ;
Gajra, Ajeet ;
Bhatia, Smita ;
Katheria, Vani ;
Klapper, Shira ;
Hansen, Kurt ;
Ramani, Rupal ;
Lachs, Mark ;
Wong, F. Lennie ;
Tew, William P. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (25) :3457-3465
[10]   Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality [J].
Jorgensen, T. L. ;
Hallas, J. ;
Friis, S. ;
Herrstedt, J. .
BRITISH JOURNAL OF CANCER, 2012, 106 (07) :1353-1360